153 related articles for article (PubMed ID: 29623585)
1. The effect of dose escalation for large squamous cell carcinomas of the anal canal.
Prasad RN; Elson J; Kharofa J
Clin Transl Oncol; 2018 Oct; 20(10):1314-1320. PubMed ID: 29623585
[TBL] [Abstract][Full Text] [Related]
2. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival.
Shah NK; Qureshi MM; Dyer MA; Truong MT; Mak KS
J Gastrointest Cancer; 2021 Mar; 52(1):229-236. PubMed ID: 32152823
[TBL] [Abstract][Full Text] [Related]
3. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
4. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
5. Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.
Brower JV; Chen S; Bassetti MF; Yu M; Harari PM; Ritter MA; Baschnagel AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):985-993. PubMed ID: 27869098
[TBL] [Abstract][Full Text] [Related]
6. Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base.
Amini A; Jones BL; Ghosh D; Schefter TE; Goodman KA
Cancer; 2017 Jan; 123(2):228-236. PubMed ID: 27571233
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).
Faivre JC; Peiffert D; Vendrely V; Lemanski C; Hannoun-Levi JM; Mirabel X; Stanbury T; Salleron J; Guillemin F
Radiother Oncol; 2018 Dec; 129(3):463-470. PubMed ID: 30172453
[TBL] [Abstract][Full Text] [Related]
9. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
10. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
11. Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
Wegner RE; Abel S; Hasan S; White RJ; Raj M; Monga D; Finley G; McCormick J; Kirichenko AV
Am J Clin Oncol; 2019 Jun; 42(6):519-526. PubMed ID: 31136369
[TBL] [Abstract][Full Text] [Related]
12. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.
Schiller DE; Cummings BJ; Rai S; Le LW; Last L; Davey P; Easson A; Smith AJ; Swallow CJ
Ann Surg Oncol; 2007 Oct; 14(10):2780-9. PubMed ID: 17638059
[TBL] [Abstract][Full Text] [Related]
14. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus, radiation dose and survival of patients with anal cancer.
Kabarriti R; Brodin NP; Ohri N; Narang R; Huang R; Chuy JW; Rajdev LN; Kalnicki S; Guha C; Garg MK
Acta Oncol; 2019 Dec; 58(12):1745-1751. PubMed ID: 31282249
[No Abstract] [Full Text] [Related]
16. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
[TBL] [Abstract][Full Text] [Related]
17. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
18. Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
Ben-Josef E; Moughan J; Ajani JA; Flam M; Gunderson L; Pollock J; Myerson R; Anne R; Rosenthal SA; Willett C
J Clin Oncol; 2010 Dec; 28(34):5061-6. PubMed ID: 20956625
[TBL] [Abstract][Full Text] [Related]
19. Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.
Untiedt S; Rolf D; Scobioala S; Wolters H; Elsayad K; Oertel M; Kittel C; Pascher A; Rijcken E; Ullerich H; Glasbrenner B; Eich HT
Strahlenther Onkol; 2023 Aug; 199(8):749-760. PubMed ID: 36862155
[TBL] [Abstract][Full Text] [Related]
20. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
